350 related articles for article (PubMed ID: 9463379)
1. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
O'Farrell AM; Liu Y; Moore KW; Mui AL
EMBO J; 1998 Feb; 17(4):1006-18. PubMed ID: 9463379
[TBL] [Abstract][Full Text] [Related]
2. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation.
O'Farrell AM; Parry DA; Zindy F; Roussel MF; Lees E; Moore KW; Mui AL
J Immunol; 2000 May; 164(9):4607-15. PubMed ID: 10779764
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
4. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
Williams L; Bradley L; Smith A; Foxwell B
J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
Rahaman SO; Vogelbaum MA; Haque SJ
Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
10. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.
Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J
J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
Carl VS; Gautam JK; Comeau LD; Smith MF
J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages.
Lim S; Caramori G; Tomita K; Jazrawi E; Oates T; Chung KF; Barnes PJ; Adcock IM
Allergy; 2004 May; 59(5):505-14. PubMed ID: 15080831
[TBL] [Abstract][Full Text] [Related]
13. Expression cloning and characterization of a human IL-10 receptor.
Liu Y; Wei SH; Ho AS; de Waal Malefyt R; Moore KW
J Immunol; 1994 Feb; 152(4):1821-9. PubMed ID: 8120391
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
Demoulin JB; Van Snick J; Renauld JC
Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517
[TBL] [Abstract][Full Text] [Related]
15. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
17. IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms.
Levings MK; Schrader JW
J Immunol; 1999 May; 162(9):5224-9. PubMed ID: 10227996
[TBL] [Abstract][Full Text] [Related]
18. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
[TBL] [Abstract][Full Text] [Related]
19. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements.
Lai CF; Ripperger J; Morella KK; Jurlander J; Hawley TS; Carson WE; Kordula T; Caligiuri MA; Hawley RG; Fey GH; Baumann H
J Biol Chem; 1996 Jun; 271(24):13968-75. PubMed ID: 8662928
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
